©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 110127
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.110127
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.110127
Correction to: Prohibitin 1 inhibits cell proliferation and induces apoptosis via the p53-mediated mitochondrial pathway in vitro
Juan-Juan Shi, Shuang-Suo Dang, Department of Infectious Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, Shaanxi Province, China
Author contributions: Shi JJ and Dang SS participated in drafting and revising the manuscript.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Corresponding author: Shuang-Suo Dang, PhD, Professor, Department of Infectious Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, No. 157 Xiwu Road, Xi’an 710004, Shaanxi Province, China. dang212@126.com
Received: June 3, 2025
Revised: June 10, 2025
Accepted: June 19, 2025
Published online: July 15, 2025
Processing time: 44 Days and 23.7 Hours
Revised: June 10, 2025
Accepted: June 19, 2025
Published online: July 15, 2025
Processing time: 44 Days and 23.7 Hours
Abstract
Correction to “Prohibitin 1 inhibits cell proliferation and induces apoptosis via the p53-mediated mitochondrial pathway in vitro. World J Gastrointest Oncol 2024; 16(2): 398-413 [PMID: 38425403 DOI: 10.4251/wjgo.v16.i2.398]”. In this article, Figures 4E and F, and 6I need to be corrected.
Core Tip: This manuscript is to add a correction note to “Prohibitin 1 inhibits cell proliferation and induces apoptosis via the p53-mediated mitochondrial pathway in vitro. World J Gastrointest Oncol 2024; 16(2): 398-413 [PMID: 38425403 DOI: 10.4251/wjgo.v16.i2.398]”.